Supplementary Methods
Locomotor activity, temporal order, spatial and novel object recognition tasks were performed as previously described (Huang et al., 2014 , Papaleo et al., 2008 , Barker et al., 2007 . A discrimination index calculated as the ratio of the amount of time spent exploring the test object over the total time spent exploring both objects was used to measure the recognition memory.
Locomotor activity with amphetamine treatment. Mice were tested in the same open field arenas used in the object recognition tasks. To avoid potential confounding effects of the implanted cable with the video tracking software and for replication purposes, for some in vivo microdialysis experiments (i.e. In vivo microdialysis. Vertical concentric dialysis probes, with a dialysing portion of 2 mm for dorsal striatum and mPFC and 1 mm for nucleus accumbens shell, were prepared using AN69 fibers (Hospal Dasco, Bologna, Italy), as previously described (De Luca et al., 2014) . Briefly, mice were anaesthetized with Pentobarbital 10% (3ml/kg ip) and then placed in a stereotaxic frame (Kopf Instruments, Tujunga, CA). The probe was implanted in the mPFC, dorsal striatum or nucleus accumbens shell (mPFC: A+1.9; L±0.1 V-3.0; dorsal striatum: AP+1.1; ML±1.7 DV-3.8; NAcc shell: AP+1.4; ML0.4; DV-4.8 all from bregma (Franklin and Paxinos, 1997) . Analytical procedure started 24-26 hours after surgery and probes were perfused with Ringer's solution, 1 µl/min, and 20-min fractions were collected for 1 hour and after acute amphetamine (1.5 mg/kg i.p) for other 3 hours.
Further assessments were performed in the Nucleus Accumbens Shell the following day perfusing with ringer solution 1 µl/min and 10-min fractions for 30 minutes in basal conditions, then 2 hours with eticlopride (1µM) infusion by reverse microdialysis (after 30 minutes ip amphetamine challenge), and another 1 hour with ringer solution 1 µl/min. Extracellular dopamine (DA) levels were quantified using an HPLC apparatus equipped with a reverse-phase column (C83.5 m, Waters, Milford, USA) and a coulometric electrochemical detector (ESA Coulochem II, Bedford, USA). At the end, mice were sacrificed and their brains were removed and stored in formalin (8%) before histological analysis. Brains were cut in serial coronal slices (100 m) to locate the placement of the microdialysis probe.
Slice surface biotinylation. Mice were anaesthetized with isofluorane and decapitated. The brain was sectioned in cold carboxygenated ACSF (124 mM NaCl, 3 mM KCl, 2 mM CaCl2, 25 mM NaHCO3, 1.1 mM NaH2PO4, 2mM MgSO4, and 10 mM D-glucose, equilibrated with 95% O2 and 5% CO2 to yield a pH 7.4.) on a vibrating microtome at a thickness of 300 μm. Striatum and prefrontal cortex were dissected from coronal slices. Before starting the surface biotinylation reaction, and in order to ensure a gradual cooling of the cells, the tissues were washed twice for 5 min in ice-cold ASCF buffer. The filters holding the tissues were transferred to a well containing an excess of biotinylation reagent solution of 100 μM NHS-SS-biotin (Pierce) in ASCF. After 45 min of incubation, the tissues were transferred to another well and washed twice with the ASCF buffer containing 200 mM Lysine (Sigma), to block all reactive NHS-SS-biotin in excess. The tissues were washed twice with ice-cold ASCF and immediately placed on ice to mechanically disrupt the tissue in 500 µl of lysis buffer (1% TX-100, PBS1X and a cocktail of protease inhibitors (Sigma). To discard extra debris, homogenates were centrifuged for 5 min at 4°C at 13 000 r.p.m. and supernatants were collected. To precipitate the biotinylated proteins from the homogenates 50 µl of immobilized Streptavidin beads (Pierce) were added to the samples and the mixture was rotating for three hours at 4°C. The precipitates were collected by a brief centrifugation, mixed with 50 µl of SDS-PAGE loading buffer, boiled for 5 minutes and stored at -80°C until use.
Antibodies and Western Blot Analyses. The anti-phospho Akt (Thr-308, #2965) and anti-Akt (#9272) were purchased from Cell Signaling Technology (Beverly, MA); while the anti-phospho tyrosine hydroxylase (Ser 40) (pTH, AB5935), the anti-tyrosine hydroxylase (TH, AB152) were purchased from Merck Millipore (Darmstadt, Germany). Dopamine D2 receptor (sc-5303), synaptophysyns (sc-365488) and transferrin receptor (sc-21011) were purchased from Santa Cruz Biotechnology (Heidelberg, Germany), and the anti-actin antibody (A2066) from Sigma Aldrich (Milan, Italy). Western blot analyses of brain samples were performed as described in (Beaulieu et al., 2004) . Briefly, mice were euthanized by decapitation. PFC and striatum were rapidly dissected on an ice-cold surface and frozen in dry ice before protein extraction. Tissue samples were homogenized in boiling 1% SDS solution supplemented with inhibitor of protease and phosphatase (Sigma Aldrich, Milan, Italy) and boiled for 5 min. Protein concentrations were measured using a DC-protein assay (Bio-Rad, Hercules, CA). Protein extracts were separated on precast 10% SDS/PAGE (Biorad, Milan, Italy) and transferred to nitrocellulose membranes. Blots were incubated with primary antibodies overnight at 4°C. Immune complexes were detected using appropriate peroxidase-conjugated secondary antibodies (Thermo Fisher Scientific, IL, USA) and a chemiluminescent reagent (ECL prime; GE Healthcare Europe GmbH, Milan, Italy). Densitometric analysis was performed by ImageQuantTL software (GE Healthcare Europe GmbH, Milan, Italy).
For quantitative analysis, total proteins were used as loading controls for phosphoprotein signals, while actin was used for the total proteins. Results were normalized to respective control conditions.
Supplementary Discussion
The temporal order object recognition, but not the novel object and spatial object recognition tasks depends on the mPFC
In our experiments, we used the novel object recognition task just as a control for general cognitive and exploratory abilities not dependent on the PFC. Indeed, a number of studies demonstrate that permanent or temporary lesions of the mPFC or specific catecholaminergic depletion within the mPFC does not affect the novel object recognition task (Cross et al., 2012 , Nelson et al., 2011 , Hannesson et al., 2004 , Mitchell and Laiacona, 1998 , Barker et al., 2007 . In agreement, we found that cognitive performance in the novel object recognition, which rely uniquely on the perirhinal cortex, were completely spared by Arc genetic disruption. That is, Arc knockout mice performed as well as wild-type mice in the novel object recognition task ( Figure 2C ). In contrast, we used the temporal order object recognition task to assess PFC-dependent cognitive functions. Performance in this task critically relies on the mPFC and its networks as demonstrated by a series of inactivation or lesion studies of the mPFC (e.g. (Hannesson et al., 2004 , Barker et al., 2007 , Mitchell and Laiacona, 1998 ). Moreover, experimental data suggest that cognitive performance on this task involves dopamine transmission. Indeed, administration of an agonist for the dopamine D1 receptors before the memory testing trial improves the ability to retrieve previously acquired temporal information (Lejeune et al., 2013 , Hotte et al., 2005 . In agreement with this literature, and to directly test in the Arc knockout mouse model the involvement of dopaminergic pathways in PFC-dependent temporal order cognitive function, we found that the injection the dopamine D1 agonist SKF38393 in the mPFC was able to rescue the recency memory deficits of Arc+/-and (partially) in Arc-/-mice ( Figure 7A -B).
Memory and social impairments in Arc mutant mice are not influenced by changes in locomotor activity
In our general health screening of Arc knockout mice, we found no Arc genotype-dependent differences in motor ability measures including wire hanging, rearing, digging and grooming (Table   S1 ). Similarly, Arc knockout mice presented no abnormalities in trunk curl, positional passivity, exploration or reflexes including righting, eye blink, ear twitch, whisker twitch, forepaw reaching, and petting escape compared to the control group (Table S1 ). Instead, we found a slight hyperactive phenotype in Arc-/-, but not in Arc+/-mice, that was only evident in the first 5-10 minutes of exposure to the open field arena (Figure 3) . We can certainly exclude that this locomotor phenotype influenced the behavioral impairments we found in cognitive, social, and PPI tasks. Indeed, Arc genetic disruption was without effect on exploration in any of the object recognition tasks used ( Figure S2 ).
Furthermore, Arc genetic disruption had no effect on novel object recognition memory performance ( Figure 2C ). Moreover, no differences were found in exploration of the 3 chambers in the social task ( Figure S1 ) nor in the basal movement and startle-elicited reactions in the startle/PPI test ( Figure 1A ).
Finally, Arc+/-which did not have any locomotor alteration whatsoever in basal situations ( Figure   3A -B), still showed clear deficits in the temporal order object recognition task (Figure 2A ), spatial object recognition task ( Figure 2B ), and social novelty task ( Figure 1D ). In conclusion, several different pieces of evidence support that the memory and social impairments in Arc mutant mice cannot be attributed to a general impairment of arousal or changes in locomotor activity.
Amphetamine-induced locomotion in relationship to dopamine neurotransmission in the nucleus accumbens shell and PFC
It has been reported that amphetamine-induced locomotion is more related to an increase in accumbens dopamine neurotransmission than to dorsal striatum. Moreover, the shell region of the accumbens has a preferential involvement in psychostimulant-induced locomotion (for example (Heidbreder and Feldon, 1998 , Ikemoto, 2002 , Parkinson et al., 1999 ). In agreement with this previous literature, we indeed found an increased release of dopamine in the nucleus accumbens shell in Arc knockout mice following the systemic amphetamine injection ( Figure 5C-D) . In addition, amphetamine-induced locomotor activity does not only depend on increased striatal dopamine release, but also reflects the integrated effects of multiple brain circuits including the prefrontal cortex (PFC). This has been reported repeatedly in the literature with both pharmacological and molecular genetic manipulations. For example, Vezina et al., (Vezina et al., 1991) demonstrated in rats that acute increases in dopamine transmission in the PFC by local injections of amphetamine inhibit the known locomotor-activating effects of amphetamine in the nucleus accumbens. Further, intra-mPFC injections of the D1 dopamine receptor antagonist SCH-23390, but not other dopamine antagonists with greater affinities for noradrenergic, serotonergic and D2 dopamine receptors, enhanced the locomotion induced by intra-Nucleus Accumbens amphetamine. Finally, motor stereotypies induced by higher doses of systemic amphetamine (2.5-10 mg/kg) are reported to be increased by mPFC dopamine depletion (Sokolowski and Salamone, 1994 , Carter and Pycock, 1980 , Espejo and Minano, 2001 ). These findings provide direct evidence for the involvement of mPFC in the expression of amphetamine-induced locomotion. Other evidence report that locomotor activity induced by exposure to novel environments or amphetamine is sensitive to frontal dopaminergic input (Tzschentke, 2001) . For example, increase of mesofrontal dopamine inputs by pharmacological or genetic manipulation is associated with suppression of psychomotor activity (Flores et al., 2005 , Tzschentke, 2001 ). Our own recent paper (Mastwal et al., 2014) provides further evidence that optogenetic enhancement of frontal dopamine input leads to suppression of amphetamine induced locomotor response, which is exactly the complement of loss of Arc function-induced hypofrontal dopamine and amplified psychomotor response.
We provided evidence that amphetamine-supersensitivity in Arc knockout mice is paralleled by an increased dopamine release specifically in the nucleus accumbens shell (Figure 5C-D) . This is in agreement with previous evidence reporting a preferential involvement of the shell region in psychostimulant-induced locomotion (Heidbreder and Feldon, 1998 , Ikemoto, 2002 , Parkinson et al., 1999 . Similarly, other evidence did report that amphetamine-induced locomotion might be more related to an increase in accumbens dopamine neurotransmission than to dorsal striatum (for example (Ikemoto, 2002) ).
TH levels, dopamine and norepinephrine in the PFC
Despite initial evidence that the total NE content in the PFC of Arc knockout mice is not altered (Figure S3 ), the lack of significant difference in total TH protein in the PFC of Arc mutant mice compared to wild-type mice might reflect compensatory changes in PFC norepinephrine fibers. These fibers, which normally express minimal TH, directly uptake dopamine for norepinephrine synthesis.
In Arc -/-mice, TH levels in dopamine axons and dopamine terminal release might be reduced together and TH levesl in NE axons might be upregulated to compensate for the reduction of extracellular dopamine. Consequently, the total amount of TH in PFC may still remain constant. Total time spent exploring the two objects presented during the 5 minutes sample phases 1, 2 and 3 of the temporal order recognition task displayed by Arc+/+, +/-and -/-littermates naïve (N=18-20/group) (A) and treated 15 minutes before the retrieval phase of the temporal order object recognition task with vehicle or the dopamine D1 agonist SKF38393 (0.06µg in 0.3µl), bilaterally microinjected in the mPFC (N=5-15/group) (B). Total time spent exploring the two objects presented during the 10 minutes of the acquisition sample 1 and 5 minutes of the test session of the spatial object recognition task (N=17-22/group) (D) and the 10 minutes of the acquisition session sample 1 and 5 minutes of the test session of the novel object recognition task (N=6-12/group) displayed by Arc +/+, +/-, and -/-littermates. , showing significant reduction after SCH23390 injection compared to before injection in Arc+/+ animals (***p<0.0002, paired t-test). N=5/group. All the error bars indicate SEM. (C) Two-photon images of the frontal cortex from Arc+/+ and Arc-/-mice in the absence of GCaMP6 labeling (left and middle panels) show that the destabilized GFP reporter knocked into the Arc locus in Arc-/-mice was relatively dim at the microscope setting used for calcium imaging. The contribution of Arc-promoter-driven GFP expression to the overall image intensity is two orders of magnitude smaller than that of GCaMP6 (right panel). Therefore, the expression of GFP does not significantly affect the calculation of calcium signals (ΔF/F). Scale bar, 30 μm. Table S1 . General Health. Arc-/-and +/-mice were indistinguishable from their Arc+/+ littermates on all general health parameters measured, including physical and reflex functions. Physical characteristics, motoric abilities, sensory reflexes and empty cage behavior displayed by Arc+/+, +/-and -/-mice. Values represent percentage or mean ±SEM. n=14-22/group. No significant genotype differences were detected. Thus genetically engineered male mice with Arc null mutation were physically capable of conducting the battery of behavioral tasks.
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